Literature DB >> 15045525

Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis.

Stefan Drinda1, Sybille Franke, Michael Rüster, Peter Petrow, Oliver Pullig, Günter Stein, Gert Hein.   

Abstract

OBJECTIVES: Generation of advanced glycation end products (AGE) is an inevitable process in vivo and can be accelerated under pathologic conditions such as oxidative stress, e.g. in rheumatoid arthritis (RA). This process is mediated by the AGE-specific receptor (RAGE). In this study we analysed the presence of RAGE in RA and osteoarthritic (OA) synovial tissue using immunohistology.
METHODS: Frozen synovial tissue samples from 11 RA patients and 12 OA patients were treated with goat anti-RAGE immunoglobulin G (IgG) and rabbit antigoat IgG. Immunostaining was visualised with streptavidin horse radish peroxidase (chromogen amino-ethyl-carbazole). Cell differentiation was performed with antibodies against CD68, CD45RO, and CD20.
RESULTS: In 9/11 RA and 8/12 OA synovial specimens, RAGE was detected in synovial lining, sublining, and stroma. In RA, many T cells (CD45RO(+)) and some macrophages (CD68(+)) showed positive immunostaining for RAGE, whereas B cells were mostly negative. We found no difference in staining patterns between the RA and OA samples.
CONCLUSIONS: We detected RAGE in RA and OA synovial tissue. The presence of RAGE on macrophages, T cells, and some B cells suggests its role in the pathogenesis of inflammatory joint disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15045525     DOI: 10.1007/s00296-004-0456-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  16 in total

Review 1.  Pathophysiology of advanced glycation end-products in renal failure.

Authors:  T Miyata; Y Iida; K Horie; Z Cai; S Sugiyama; K Maeda
Journal:  Nephrol Dial Transplant       Date:  1996       Impact factor: 5.992

Review 2.  The role of the Maillard reaction in other pathologies: Alzheimer's disease.

Authors:  C A Colaco; M D Ledesma; C R Harrington; J Avila
Journal:  Nephrol Dial Transplant       Date:  1996       Impact factor: 5.992

Review 3.  Protein glycation in the kidney: role in diabetes and aging.

Authors:  H Vlassara
Journal:  Kidney Int       Date:  1996-06       Impact factor: 10.612

4.  Effects of advanced glycation end-products on the proliferation and differentiation of osteoblast-like cells.

Authors:  A D McCarthy; S B Etcheverry; L Bruzzone; A M Cortizo
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

5.  Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis.

Authors:  M A Friedlander; Y C Wu; A Elgawish; V M Monnier
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

6.  Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis.

Authors:  M Takahashi; M Suzuki; K Kushida; S Miyamoto; T Inoue
Journal:  Br J Rheumatol       Date:  1997-06

Review 7.  Advanced glycation end-products and atherosclerosis.

Authors:  H Vlassara
Journal:  Ann Med       Date:  1996-10       Impact factor: 4.709

8.  Advanced glycation endproducts stimulate interleukin-6 production by human bone-derived cells.

Authors:  M Takagi; S Kasayama; T Yamamoto; T Motomura; K Hashimoto; H Yamamoto; B Sato; S Okada; T Kishimoto
Journal:  J Bone Miner Res       Date:  1997-03       Impact factor: 6.741

9.  Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders.

Authors:  M Takahashi; K Kushida; T Ohishi; K Kawana; H Hoshino; A Uchiyama; T Inoue
Journal:  Arthritis Rheum       Date:  1994-05

Review 10.  Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs.

Authors:  P J Thornalley
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1998-11       Impact factor: 1.770

View more
  16 in total

1.  Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjögren's syndrome.

Authors:  Carol Stewart; Seunghee Cha; Robert M Caudle; Kathleen Berg; Joseph Katz
Journal:  Rheumatol Int       Date:  2008-01-30       Impact factor: 2.631

2.  Epistasis between ADIPOQ rs1501299 and PON1 rs662 polymorphisms is potentially associated with the development of knee osteoarthritis.

Authors:  Javier Fernández-Torres; Gabriela Angélica Martínez-Nava; Yessica Zamudio-Cuevas; Karina Martínez-Flores; Rolando Espinosa-Morales
Journal:  Mol Biol Rep       Date:  2019-02-08       Impact factor: 2.316

3.  A multicellular signal transduction network of AGE/RAGE signaling.

Authors:  Sowmya Soman; Rajesh Raju; Varot K Sandhya; Jayshree Advani; Aafaque Ahmad Khan; H C Harsha; T S Keshava Prasad; P R Sudhakaran; Akhilesh Pandey; Puneeth K Adishesha
Journal:  J Cell Commun Signal       Date:  2012-11-19       Impact factor: 5.782

Review 4.  [The aging lens--new concepts for lens aging].

Authors:  J Dawczynski; J Strobel
Journal:  Ophthalmologe       Date:  2006-09       Impact factor: 1.059

Review 5.  Understanding RAGE, the receptor for advanced glycation end products.

Authors:  Angelika Bierhaus; Per M Humpert; Michael Morcos; Thoralf Wendt; Triantafyllos Chavakis; Bernd Arnold; David M Stern; Peter P Nawroth
Journal:  J Mol Med (Berl)       Date:  2005-08-24       Impact factor: 4.599

6.  The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis.

Authors:  Gert E Hein; Markus Köhler; Peter Oelzner; Günter Stein; Sybille Franke
Journal:  Rheumatol Int       Date:  2004-12-03       Impact factor: 2.631

7.  RAGE mRNA expression and its correlation with nuclear factor kappa beta mRNA expression in inflamed human periradicular tissues.

Authors:  Michael Crabtree; Roberta Pileggi; Indraneel Bhattacharyya; Robert Caudle; Federico Perez; Joseph Riley; Frank Vertucci; Joseph Katz
Journal:  J Endod       Date:  2008-04-15       Impact factor: 4.171

8.  Measurement of advanced glycation endproducts in skin of patients with rheumatoid arthritis, osteoarthritis, and dialysis-related spondyloarthropathy using non-invasive methods.

Authors:  Tomoko Matsumoto; Toshiyuki Tsurumoto; Hideo Baba; Makoto Osaki; Hiroshi Enomoto; Akihiko Yonekura; Hiroyuki Shindo; Toshio Miyata
Journal:  Rheumatol Int       Date:  2007-07-25       Impact factor: 2.631

9.  Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells.

Authors:  Sybille Franke; Manfred Sommer; Christiane Rüster; Tzvetanka Bondeva; Julia Marticke; Gunther Hofmann; Gert Hein; Gunter Wolf
Journal:  Arthritis Res Ther       Date:  2009-09-07       Impact factor: 5.156

Review 10.  Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior.

Authors:  Nontaphat Leerach; Ai Harashima; Seiichi Munesue; Kumi Kimura; Yu Oshima; Hisanori Goto; Hiroshi Yamamoto; Haruhiro Higashida; Yasuhiko Yamamoto
Journal:  Glycoconj J       Date:  2020-10-27       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.